Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NETO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TNRC18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C17orf51 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC101929219 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASCL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP1R12B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAMD14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CELF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KY - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPR161 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB39A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LAIR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR51M1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AMER3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCBP1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL45P2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELANE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLBD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on